Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence in cancer target identification and drug discovery
Yujie You, Xin Lai, Yi Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

TTD: Therapeutic Target Database describing target druggability information
Ying Zhou, Yintao Zhang, Donghai Zhao, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1465-D1477
Open Access | Times Cited: 212
Artificial intelligence for drug discovery: Resources, methods, and applications
Wei Chen, Xuesong Liu, Sanyin Zhang, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 691-702
Open Access | Times Cited: 120
Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology
Ajay Vikram Singh, Vaisali Chandrasekar, Namuna Paudel, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114784-114784
Open Access | Times Cited: 81
Machine learning for synergistic network pharmacology: a comprehensive overview
Fatima Noor, Muhammad Asif, Usman Ali Ashfaq, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 3
Closed Access | Times Cited: 80
Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery
Shruti Singh, Rajesh Kumar, Shuvasree Payra, et al.
Cureus (2023)
Open Access | Times Cited: 66
Artificial Intelligence in Medicine and Dentistry
Marin Vodanović, Marko Subašić, Denis Milošević, et al.
Acta Stomatologica Croatica (2023) Vol. 57, Iss. 1, pp. 70-84
Open Access | Times Cited: 51
Artificial intelligence in drug development
Kang Zhang, Xin Yang, Yifei Wang, et al.
Nature Medicine (2025) Vol. 31, Iss. 1, pp. 45-59
Closed Access | Times Cited: 11
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach
Alberto Ocaña, Atanasio Pandiella, Cristian Privat, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives
Nian‐Nian Zhong, Hanqi Wang, Xinyue Huang, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 52-74
Closed Access | Times Cited: 40
Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment
Kirthika Senthil Kumar, Vanja Mišković, Agata Blasiak, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 33
Artificial Intelligence in Drug Discovery and Development
Kit‐Kay Mak, Yi-Hang Wong, Mallikarjuna Rao Pichika
Springer eBooks (2023), pp. 1-38
Closed Access | Times Cited: 30
Future of Artificial Intelligence Applications in Cancer Care: A Global Cross-Sectional Survey of Researchers
Bernardo Pereira Cabral, Luiza Amara Maciel Braga, Shabbir Syed-Abdul, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3432-3446
Open Access | Times Cited: 25
Artificial intelligence-aided optical imaging for cancer theranostics
Mengze Xu, Zhiyi Chen, Junxiao Zheng, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 62-80
Closed Access | Times Cited: 23
Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics
Shreya Singh Beniwal, Paula Lamo, Ajeet Kaushik, et al.
Biosensors (2023) Vol. 13, Iss. 10, pp. 926-926
Open Access | Times Cited: 23
From understanding diseases to drug design: can artificial intelligence bridge the gap?
Anju Choorakottayil Pushkaran, Alya A. Arabi
Artificial Intelligence Review (2024) Vol. 57, Iss. 4
Open Access | Times Cited: 14
Artificial intelligence in metabolomics: a current review
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 13
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 12
Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review
Amit Anthwal, Akshat Uniyal, Jitender Gairolla, et al.
Journal of Industrial Information Integration (2024) Vol. 38, pp. 100562-100562
Closed Access | Times Cited: 10
The Art of Finding the Right Drug Target: Emerging Methods and Strategies
Zi-Chang Jia, Xue Yang, Yikun Wu, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 896-914
Open Access | Times Cited: 10
The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents
Su Jeong Park, In‐ho Song, Gyu Seong Yeom, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116106-116106
Open Access | Times Cited: 9
Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications
Peter Chinedu Agu, Chidiebere Nwiboko Obulose
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 9
Artificial Intelligence in Drug Discovery and Development
Kit‐Kay Mak, Yi-Hang Wong, Mallikarjuna Rao Pichika
Springer eBooks (2024), pp. 1461-1498
Closed Access | Times Cited: 9
Integrating Artificial Intelligence in Pediatric Healthcare: Parental Perceptions and Ethical Implications
Camelia Elena Berghea, Marcela Daniela Ionescu, Radu Marian Gheorghiu, et al.
Children (2024) Vol. 11, Iss. 2, pp. 240-240
Open Access | Times Cited: 8
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity
Hakan Aslan, Gioele Renzi, Andrea Angeli, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1929-1941
Open Access | Times Cited: 8
Applications of Artificial Intelligence in Prostate Cancer Care: A Path to Enhanced Efficiency and Outcomes
Irbaz Bin Riaz, Stephanie A. Harmon, Zhijun Chen, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top